Stock News

Jones Collombin Investment Counsel Holding In Methanex (MEOH) Was Has Lifted; Merck & Co (MRK) Holder Martin Currie LTD Has Boosted Stake by $2.17 Million

Methanex Corporation (NASDAQ:MEOH) Logo

Martin Currie Ltd increased its stake in Merck & Co Inc (MRK) by 20.32% based on its latest 2017Q4 regulatory filing with the SEC. Martin Currie Ltd bought 38,824 shares as the company’s stock declined 4.63% with the market. The institutional investor held 229,924 shares of the health care company at the end of 2017Q4, valued at $12.94 million, up from 191,100 at the end of the previous reported quarter. Martin Currie Ltd who had been investing in Merck & Co Inc for a number of months, seems to be bullish on the $158.41 billion market cap company. The stock increased 0.32% or $0.19 during the last trading session, reaching $58.83. About 9.65M shares traded. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since April 22, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Jones Collombin Investment Counsel Inc increased its stake in Methanex Corp (MEOH) by 138.08% based on its latest 2017Q4 regulatory filing with the SEC. Jones Collombin Investment Counsel Inc bought 57,730 shares as the company’s stock declined 0.59% with the market. The institutional investor held 99,540 shares of the major chemicals company at the end of 2017Q4, valued at $6.03 million, up from 41,810 at the end of the previous reported quarter. Jones Collombin Investment Counsel Inc who had been investing in Methanex Corp for a number of months, seems to be bullish on the $5.38B market cap company. The stock decreased 1.04% or $0.7 during the last trading session, reaching $66.8. About 1.09 million shares traded or 44.68% up from the average. Methanex Corporation (NASDAQ:MEOH) has risen 32.18% since April 22, 2017 and is uptrending. It has outperformed by 20.63% the S&P500.

Among 13 analysts covering Methanex Corporation (NASDAQ:MEOH), 6 have Buy rating, 1 Sell and 6 Hold. Therefore 46% are positive. Methanex Corporation had 76 analyst reports since July 27, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cowen & Co on Friday, July 28. The rating was maintained by Cowen & Co on Wednesday, September 9 with “Outperform”. On Wednesday, January 3 the stock rating was maintained by Scotia Capital with “Hold”. TD Securities upgraded the shares of MEOH in report on Friday, July 31 to “Buy” rating. The rating was maintained by Alembic with “Buy” on Thursday, July 27. On Wednesday, March 2 the stock rating was upgraded by Raymond James to “Outperform”. UBS downgraded Methanex Corporation (NASDAQ:MEOH) rating on Monday, October 31. UBS has “Sell” rating and $31 target. The firm earned “Hold” rating on Friday, December 22 by RBC Capital Markets. The stock has “Outperform” rating by Cowen & Co on Wednesday, November 30. The stock of Methanex Corporation (NASDAQ:MEOH) earned “Market Perform” rating by Raymond James on Tuesday, January 3.

Jones Collombin Investment Counsel Inc, which manages about $304.23M US Long portfolio, decreased its stake in Apple Inc (NASDAQ:AAPL) by 3,272 shares to 55,860 shares, valued at $9.45 million in 2017Q4, according to the filing. It also reduced its holding in Enbridge Inc (NYSE:ENB) by 10,361 shares in the quarter, leaving it with 52,125 shares, and cut its stake in General Dynamics Corp (NYSE:GD).

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 20 have Buy rating, 0 Sell and 4 Hold. Therefore 83% are positive. Merck & Co. Inc. had 88 analyst reports since August 13, 2015 according to SRatingsIntel. Barclays Capital downgraded the stock to “Equal-Weight” rating in Monday, October 30 report. Jefferies maintained it with “Hold” rating and $53 target in Tuesday, June 14 report. Jefferies maintained the shares of MRK in report on Monday, July 17 with “Sell” rating. As per Monday, February 26, the company rating was maintained by Jefferies. On Friday, January 13 the stock rating was initiated by Bryan Garnier & Cie with “Buy”. Leerink Swann maintained Merck & Co., Inc. (NYSE:MRK) on Tuesday, February 6 with “Market Perform” rating. BMO Capital Markets maintained the shares of MRK in report on Wednesday, July 19 with “Buy” rating. The firm has “Outperform” rating by Credit Suisse given on Monday, February 5. Jefferies maintained the shares of MRK in report on Thursday, November 16 with “Hold” rating. The stock of Merck & Co., Inc. (NYSE:MRK) has “Market Perform” rating given on Monday, October 30 by Leerink Swann.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *